Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.
Zidavi is recommended by the Infectious Disease Society of America
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Sanjeev is currently the Country President for AstraZeneca Malaysia
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Subscribe To Our Newsletter & Stay Updated